14 May 2019
By Dr Wendy Winnall - PCFA Research Team
A non-cancerous, enlarged prostate can be treated with drugs to reduce symptoms. Drugs called 5-alpha reductase inhibitors (5-ARIs) reduce PSA levels for these men. This could be problematic, as it could hide the PSA increase caused by a small prostate tumour. Results from a new study in California have suggested that PSA suppression in 5-ARI users was not routinely accounted for during prostate cancer testing, leading to delays in prostate cancer diagnosis and worse outcomes.
To read the full article just log into the PCFA Online Community.
If you're not already a member, it is free and easy to join.
